117 related articles for article (PubMed ID: 2787675)
1. A comparison between activated protein C and des-1-41-light chain-activated protein C in reactions with type 1 plasminogen activator inhibitor.
Gladson CL; Schleef RR; Binder BR; Loskutoff DJ; Griffin JH
Blood; 1989 Jul; 74(1):173-81. PubMed ID: 2787675
[TBL] [Abstract][Full Text] [Related]
2. Platelet plasminogen activator inhibitor: purification and characterization of interaction with plasminogen activators and activated protein C.
Fay WP; Owen WG
Biochemistry; 1989 Jul; 28(14):5773-8. PubMed ID: 2505842
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of protein C-dependent clot lysis: role of plasminogen activator inhibitor.
Sakata Y; Loskutoff DJ; Gladson CL; Hekman CM; Griffin JH
Blood; 1986 Dec; 68(6):1218-23. PubMed ID: 3096399
[TBL] [Abstract][Full Text] [Related]
4. Interaction of type 1 plasminogen activator inhibitor with the enzymes of the contact activation system.
Berrettini M; Schleef RR; España F; Loskutoff DJ; Griffin JH
J Biol Chem; 1989 Jul; 264(20):11738-43. PubMed ID: 2787318
[TBL] [Abstract][Full Text] [Related]
5. Protein S is a cofactor for activated protein C neutralization of an inhibitor of plasminogen activation released from platelets.
D'Angelo A; Lockhart MS; D'Angelo SV; Taylor FB
Blood; 1987 Jan; 69(1):231-7. PubMed ID: 2947643
[TBL] [Abstract][Full Text] [Related]
6. The primary plasminogen-activator inhibitors in endothelial cells, platelets, serum, and plasma are immunologically related.
Erickson LA; Hekman CM; Loskutoff DJ
Proc Natl Acad Sci U S A; 1985 Dec; 82(24):8710-4. PubMed ID: 3936043
[TBL] [Abstract][Full Text] [Related]
7. Kinetic analysis of the interaction between type 1 plasminogen activator inhibitor and vitronectin and evidence that the bovine inhibitor binds to a thrombin-derived amino-terminal fragment of bovine vitronectin.
Seiffert D; Loskutoff DJ
Biochim Biophys Acta; 1991 May; 1078(1):23-30. PubMed ID: 1710930
[TBL] [Abstract][Full Text] [Related]
8. Binding of type 1 plasminogen activator inhibitor to the extracellular matrix of cultured bovine endothelial cells.
Mimuro J; Loskutoff DJ
J Biol Chem; 1989 Mar; 264(9):5058-63. PubMed ID: 2494180
[TBL] [Abstract][Full Text] [Related]
9. The effect of divalent cations on the amidolytic activity of bovine plasma activated protein C and des-1-41-light chain activated protein C.
Hill KA; Kroon LM; Castellino FJ
J Biol Chem; 1987 Jul; 262(20):9581-6. PubMed ID: 3597424
[TBL] [Abstract][Full Text] [Related]
10. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
[TBL] [Abstract][Full Text] [Related]
11. Kinetic analysis of the interactions between plasminogen activator inhibitor 1 and both urokinase and tissue plasminogen activator.
Hekman CM; Loskutoff DJ
Arch Biochem Biophys; 1988 Apr; 262(1):199-210. PubMed ID: 3128176
[TBL] [Abstract][Full Text] [Related]
12. Vimentin exposed on activated platelets and platelet microparticles localizes vitronectin and plasminogen activator inhibitor complexes on their surface.
Podor TJ; Singh D; Chindemi P; Foulon DM; McKelvie R; Weitz JI; Austin R; Boudreau G; Davies R
J Biol Chem; 2002 Mar; 277(9):7529-39. PubMed ID: 11744725
[TBL] [Abstract][Full Text] [Related]
13. Structural requirements for the extracellular interaction of plasminogen activator inhibitor 1 with endothelial cell matrix-associated vitronectin.
Preissner KT; Grulich-Henn J; Ehrlich HJ; Declerck P; Justus C; Collen D; Pannekoek H; Müller-Berghaus G
J Biol Chem; 1990 Oct; 265(30):18490-8. PubMed ID: 1698787
[TBL] [Abstract][Full Text] [Related]
14. Identification of and partial characterization of platelet vitronectin: evidence for complex formation with platelet-derived plasminogen activator inhibitor-1.
Preissner KT; Holzhüter S; Justus C; Müller-Berghaus G
Blood; 1989 Nov; 74(6):1989-96. PubMed ID: 2478218
[TBL] [Abstract][Full Text] [Related]
15. The interaction of activated protein C and thrombin with the plasminogen activator inhibitor released from human endothelial cells.
de Fouw NJ; van Hinsbergh VW; de Jong YF; Haverkate F; Bertina RM
Thromb Haemost; 1987 Apr; 57(2):176-82. PubMed ID: 3496680
[TBL] [Abstract][Full Text] [Related]
16. Kinetics of inhibition of tissue-type and urokinase-type plasminogen activator by plasminogen-activator inhibitor type 1 and type 2.
Thorsen S; Philips M; Selmer J; Lecander I; Astedt B
Eur J Biochem; 1988 Jul; 175(1):33-9. PubMed ID: 3136015
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen activator inhibitor 1: development of a radioimmunoassay and observations on its plasma concentration during venous occlusion and after platelet aggregation.
Kruithof EK; Nicolosa G; Bachmann F
Blood; 1987 Nov; 70(5):1645-53. PubMed ID: 3117137
[TBL] [Abstract][Full Text] [Related]
18. Purification of active human plasminogen activator inhibitor 1 from Escherichia coli. Comparison with natural and recombinant forms purified from eucaryotic cells.
Lawrence D; Strandberg L; Grundström T; Ny T
Eur J Biochem; 1989 Dec; 186(3):523-33. PubMed ID: 2514093
[TBL] [Abstract][Full Text] [Related]
19. Epidermal plasminogen activator inhibitor (PAI) is immunologically identical to placental-type PAI-2.
Hibino T; Izaki S; Ohkuma M; Kon S; Thorsen S; Astedt B
FEBS Lett; 1988 Apr; 231(1):202-6. PubMed ID: 3129308
[TBL] [Abstract][Full Text] [Related]
20. Interaction of tissue-type plasminogen activator and plasminogen activator inhibitor 1 on the surface of endothelial cells.
Sakata Y; Okada M; Noro A; Matsuda M
J Biol Chem; 1988 Feb; 263(4):1960-9. PubMed ID: 3123483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
